Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Conditions
Locally Advanced Lung Non-Small Cell Carcinoma · Metastatic Lung Non-Small Cell Carcinoma · Stage III Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Principal Investigator (Surbhi Singhal)Moffitt Cancer Center-International Plaza, Tampa, Florida, United States
Contact: Principal Investigator (Andreas N. Saltos)Moffitt Cancer Center - McKinley Campus, Tampa, Florida, United States
Contact: Principal Investigator (Andreas N. Saltos)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Andreas N. Saltos)Moffitt Cancer Center at Wesley Chapel, Wesley Chapel, Florida, United States
Contact: Principal Investigator (Andreas N. Saltos)Case Western Reserve University, Cleveland, Ohio, United States
Contact: Principal Investigator (Matthew M. Mirsky)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Jacob Kaufman)University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Liza C. Villaruz)University of Virginia Cancer Center, Charlottesville, Virginia, United States
Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303Contact: Principal Investigator (Richard D. Hall)
Study leads
Andreas N Saltos
Principal Investigator
University Health Network Princess Margaret Cancer Center LAO